Stockreport

Celsion Delivering Doxorubicin To Cancer Tissues [Seeking Alpha]

Celsion Corporation  (CLSN) 
Last celsion corporation earnings: 11/14 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.celsion.com/investor-relations
PDF Celsion Delivering Doxorubicin To Cancer TissuesSummaryOppenheimer gives Celsion a $9.00 target and rates at "outperform" on November 21, 2017.OPTIMA study of ThermoDox [Read more]